NHAM LIPID CPG

NHAM LIPID CPG

AstraZeneca Pharmaceuticals LP

Available on Google Play
1,000+ installsFreeEducation

Updated Sep 3, 2024 ยท v1.6

CompareView on Google Play โ†—
Screenshot 1
Screenshot 2
Screenshot 3
Screenshot 4
Screenshot 5
Screenshot 6
Screenshot 7

Local guideline for cholesterol management

There is exponential growth of medical information being published every day. Modern day medicine expects the health care providers to keep up with the latest information and adapt them into their daily practice as part of best clinical practice and evidence based medicine. CPG not only plays a very important role in disseminating information but also setting the minimum standard for the country; taking into the consideration of our local needs, demands, constraints, limitations and resources allocations. The title of this CPG has changed from hyperlipidaemia to dyslipidaemia as well as addition of new sections, reflecting the emergence of new knowledge in the pathophysiology of the conditions as well as paradigm shift in diagnostic and therapeutic strategies since the first edition which was launched in 1994. The excellent traditions of the expert panels from the various sections of the practicing medical communities with interest in lipid for this CPG remains unchanged.

Version
1.6
Updated
Sep 3, 2024
Content Rating
Everyone
Installs
1,000+
Developer
AstraZeneca Pharmaceuticals LP
Website
https://www.astrazeneca.com/country-sites/malaysia.html
Email
NHAMapps@astrazeneca.com
In-app purchases
No

This app isn't currently appearing in any tracked top charts.

Rating breakdown

5โ˜…
0
4โ˜…
0
3โ˜…
0
2โ˜…
0
1โ˜…
0